NEW YORK – The number of tests for substances banned in baseball in the major league has dropped sharply since the start of the coronavirus pandemic.
There were 3,733 urine samples and 412 blood samples collected for human growth hormone testing in the year that ended with the World Series, said independent program administrator Thomas M. Martin in the annual report, Tuesday.
This is a reduction from 9322 urine samples and 2287 blood samples collected in the year ending the world series in 2019.
“The decline in the number of tests results from the pandemic and the prolonged closure of the WADA-approved anti-doping laboratory in Montreal,” Martin wrote.
The start of the regular season has been delayed from the end of March to the end of July. Each team’s schedule has gone from 162 games to 60.
There were 10 positive tests for performance-enhancing drugs: two for stanozolol (Robinson Cano and Victor Alcantara), five for boldenone (Francis Martes, Pablo Reyes, Domingo Leyba, Emmanuel Clase and Edgar Santana) and three for dehydrochloromethyltestosterone (DHCMT) (Justin Lawrence, Tres Barrera and Kent Emanuel).
91 exceptions for therapeutic use were granted, 90 for hyperactivity disorder and one for hypersomnia.
This is a reduction from 94 for the year which included 90 for ADHD and one for hypersomnia, hypogonadism and kidney disease.